Synthszr Stocks — Marmorner Bulle und Bär vor den Säulen der Börse
synthszr stocks

Unternehmens-Analyse: Accenture

Unternehmens-Analyse: Accenture

Stand 29.10.2026
HOLDSynthszr Vote

Data supports a HOLD: Accenture exited FY26 with steady growth (+5% local currency), improving margins (15.8% adjusted), strong cash generation ($11.6B FCF) and explicit FY27 targets for continued margin expansion and shareholder returns (≥$9.5B). However, FY27 guidance implies only moderate growth (3%–6% local currency; 3%–6% adjusted EPS growth), and third-party valuation snapshots place the stock at a mid-to-high teens earnings multiple, which reduces the probability of near-term multiple expansion without evidence of re-acceleration. Maintain exposure for quality and cash returns; add only on valuation-driven pullbacks or if bookings/growth trends improve beyond the guided range. (investor.accenture.com)

Zusammenfassung

Accenture plc (ACN) is a global professional services firm positioned as a “business reinvention and technology company,” delivering consulting and managed services across strategy, process/operating model change, data, technology and AI, supported by proprietary assets/platforms and ecosystem partnerships. Its scale (serving ~9,000 clients) and breadth across industries and geographies (Americas, EMEA, Asia Pacific) underpin a diversified demand base and recurring managed-services revenue streams. (investor.accenture.com) Market position remains strong in large-scale transformation programs where clients prioritize modernization and becoming “AI-ready.” Competitive advantages center on (1) deep industry/process expertise, (2) global delivery capacity and talent base, (3) ability to execute end-to-end programs (consulting through operations), and (4) strong commercial engine evidenced by sustained bookings and large-deal activity. In FY26, Accenture delivered $84.5B in new bookings (book-to-bill ~1.1) and reached a new high in quarterly $100M+ client bookings (141), indicating continued relevance in large enterprise spend. (investor.accenture.com) Recent developments (last ~1 month) are dominated by the FY26 Q4/FY26 results and FY27 outlook (released Oct 1, 2026). Accenture reported FY26 revenue of $74.2B (+6% USD; +5% local currency) and Q4 revenue of $18.7B (+6% USD; +7% local currency). Profitability improved: FY26 GAAP operating margin was 15.4% (up 70 bps YoY) and adjusted operating margin was 15.8% (up 20 bps). FY26 GAAP EPS was $13.56 (+12% YoY) and adjusted EPS was $13.97 (+8% YoY). Free cash flow was $11.6B (FCF/NI ratio 1.4), enabling $11.5B returned to shareholders in FY26. (investor.accenture.com) Guidance/outlook: for FY27, management guided to 3%–6% local-currency revenue growth, operating margin of 15.9%–16.1% (adjusted; +10 to +30 bps YoY), adjusted EPS of $14.39–$14.81 (3%–6% growth vs FY26 adjusted), and $11.0B–$11.8B free cash flow with at least $9.5B returned to shareholders. This frames a near-term setup of moderate top-line growth with incremental margin expansion and continued capital returns. (investor.accenture.com) Valuation (converted context for EUR request): with an observed EUR trading reference around ~€218 on German venues (Oct 29, 2026), and third-party valuation snapshots indicating ~18.2x trailing P/E and ~16.8x forward P/E, the stock screens as a quality compounder at a mid-to-high teens earnings multiple, consistent with a mature large-cap services leader rather than a high-growth software profile. Near/medium-term performance is likely to be driven by (a) conversion of bookings into revenue, (b) sustained margin discipline, and (c) evidence that AI-related demand translates into measurable incremental growth rather than mix-shift only. (finanzen.net)

Key Takeaways

  1. FY26 execution was solid: revenue $74.2B (+5% local currency) with improved profitability (15.8% adjusted operating margin) and adjusted EPS $13.97 (+8% YoY). (investor.accenture.com)
  2. Commercial momentum remains healthy: FY26 bookings $84.5B and Q4 bookings $22.2B (+5% local currency), supporting revenue visibility. (investor.accenture.com)
  3. FY27 guidance implies moderate growth with incremental margin expansion: 3%–6% local-currency revenue growth and 15.9%–16.1% adjusted operating margin. (investor.accenture.com)
  4. Cash generation and shareholder returns are a core part of the equity story: FY26 FCF $11.6B and $11.5B returned; FY27 plan is at least $9.5B returned. (investor.accenture.com)
  5. Valuation appears mid-teens to high-teens earnings multiple (third-party snapshot ~18x trailing, ~17x forward), leaving less room for multiple expansion unless growth re-accelerates. (stockanalysis.com)

Action-Ideen

HOLD

Base-case positioning for existing holders: FY27 guidance points to steady but not accelerating fundamentals (3%–6% local-currency revenue growth; 3%–6% adjusted EPS growth) with modest margin expansion and continued buybacks/dividends. This supports a hold for quality/defensive characteristics and cash returns, but limits near-term upside if the market is already pricing in stable execution at a mid-to-high teens P/E. ([investor.accenture.com](https://investor.accenture.com/~/media/Files/A/accenture-v4/investors/earnings-reports/2026/accenture-fourth-quarter-fiscal-2026-earnings-presentation.pdf?utm_source=openai))

Horizont: 12 Mon.

BUY

Quality-compounder entry on weakness: If the stock trades down meaningfully versus recent EUR reference levels (~€218 on Oct 29, 2026), investors can consider adding given (1) strong FCF generation ($11.6B in FY26), (2) explicit FY27 commitment to return at least $9.5B to shareholders, and (3) guided margin expansion to 15.9%–16.1%. The thesis is primarily cash-flow durability and capital return support rather than high growth. ([finanzen.net](https://www.finanzen.net/boersenplaetze/accenture?utm_source=openai))

Horizont: 18 Mon.

SELL

Risk-management trim for valuation-sensitive investors: With third-party data indicating ~18x trailing and ~17x forward P/E and FY27 guidance implying mid-single-digit growth, investors with low tolerance for drawdowns may reduce exposure if the stock rallies materially above levels justified by the guided EPS range ($14.39–$14.81) and modest margin expansion. This is a valuation discipline call rather than a deterioration call. ([stockanalysis.com](https://stockanalysis.com/stocks/acn/statistics/?utm_source=openai))

Horizont: 6 Mon.

Contrarian Insights

  • • Consensus often frames Accenture as a direct AI spending beneficiary; a more conservative read is that near-term AI work can be mix-shifting (relabeling/augmenting transformation programs) rather than adding incremental budget, which would align with management’s FY27 guidance of only 3%–6% local-currency revenue growth. (investor.accenture.com)
  • • Despite strong FY26 cash returns ($11.5B) and FY27 return commitment (≥$9.5B), the equity may behave more like a cash-flow yield/quality factor than a growth factor at current mid-to-high teens P/E; investors expecting multiple expansion without growth re-acceleration may be disappointed. (investor.accenture.com)

Quellen (8)

Accenture bei Synthszr

Subscribe free. Unsubscribe the second it sucks.

High-signal news across AI, business, UX, and tech. Every morning.